Silverarc Capital Management, LLC Athira Pharma, Inc. Transaction History

Silverarc Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$2.74 - $13.43 $27,400 - $134,300	-10,000 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$8.96 - $13.51 $89,600 - $135,100	10,000 New	10,000 $27 Million
Q4 2021 Feb 14, 2022	SELL	$9.17 - $16.39 $975,577 - $1.74 Million	-106,388 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$9.15 - $11.09 $106,066 - $128,555	-11,592 Reduced 9.83%	106,388 $998,000
Q2 2021 Aug 16, 2021	BUY	$10.24 - $20.87 $1.21 Million - $2.46 Million	117,980 New	117,980 $1.21 Million

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $20M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Silverarc Capital Management, LLC with notifications on news.